中國醫藥學院醫學系醫學士
現任：亞東紀念醫院品質管理中心主任與臨床病理科主任
行政院衛生署桃園醫院住院醫師、主治醫師、主任
檢驗醫學-解釋與諮詢、輸血醫學、家庭醫學
1. Cheng SH, Yang YC, Chen CP, Hsieh HT, Lin YC, Cheng CY, Liao KS, Chu FY*, Liu
YR*Oncogenic human papillomavirus and anal microbiota in men who have sex with men and are
living with HIV in Northern Taiwan. PLoS One. (Accepted on 2024 Oct14) (SCI)
2. Chien JY, Gu YC, Chien CC, Chang CL, Cheng HW, Chiu SW, Nee YJ, Tsai HM, Chu FY, Tang HF, Wang YL, Lin CH. Unraveling RNA contribution to the molecular origins of bacterial surface-enhanced Raman spectroscopy (SERS) signals. Sci Rep. 2024 Aug 22;14(1):19505. (SCI)
3. Chang CC, Ho JL, Lin PC, Lin CP, Tsai WT, Huang HL, Yu YB, Chen WC, Chu FY. Proactive
consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center's 12-year experience. Medicine (Baltimore). 2024 Jun 7;103(23):e38523. (SCI) (Correspondence Author)
4. Hsu MS, Chung TC, Wang PH, Cheng SL, Wu YW, Hsu JC, Tzeng BH, Lin HH, Tu CM, Chu FY, Fang CT. Revisiting the association between vitamin D deficiency and active tuberculosis: A prospective case-control study in Taiwan. J Microbiol Immunol Infect. 2024 Jun;57(3):490-497. (SCI)
5. Yang JY, Liao CH, Hung FM, Chu FY, Chiu KM. Transformation from zero tolerance to living with COVID-19 in New Taipei City, Taiwan. Experience of the FEMH "home-hotel-hospital" care model. J Formos Med Assoc. 2024 Jan;123 Suppl 1:S39-S46. (SCI)
6. Lin PC, Huang CJ, Lu YM, Huang HL, Wu ZY, Chang CC, Chu FY. Diagnostic performance of GenBody COVID-19 rapid antigen test for laboratory and non-laboratory medical professionals in real practice: A retrospective study. Medicine (Baltimore). 2023 Aug 18;102(33):e34927. (SCI) (Correspondence Author)
7. Lin PC, Chiu HP, Cheng FY, Chang CC, Chu FY. Clinical Performance of Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection in the Emergency Department and Community: A Retrospective Study. Can J Infect Dis Med Microbiol. 2022 Oct 6;2022:9447251. (SCI) (Correspondence Author)
8. Lin PC, Chang CL, Chung YH, Chang CC, Chu FY. Revisiting factors associated with blood culture positivity: Critical factors after the introduction of automated continuous monitoring blood culture systems. Medicine (Baltimore). 2022 Jul 29;101(30):e29693. (SCI) (Correspondence Author)
9. Tung KT, Peng YS, Hsu SP, Wu HY, Chiu YL, Yang JY, Pai MF, Shu KH, Pan SY, Lu HM, Lin WY, Liao CH, Chu FY, Tsai WC. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis. Hemodial Int. 2022 Jul;26(3):369-376. (SCI) (Equal Correspondence Author)
10. Chang YH, Yang HJ, Chen HW, Hsiao CW, Hsieh YC, Chan YW, Chang SW, Hwang WL, Chen WS, Cheng HH, Chou TY, Chang FP, Ho HL, Chu FY, Lo YL, Chen CJ, Tsai HF, Shiau MY. Characterization of Collapsin Response Mediator Protein 2 in Colorectal Cancer Progression in Subjects with Diabetic Comorbidity. Cells. 2022 Feb 18;11(4):727. (SCI)